Company / Operating Income
Solid Biosciences Inc. Operating Income History
FY2018-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$88.4M
FY2022
5-year range
-$119.3M / -$25.6M
FY2018-FY2022
Trend
+25.9%
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Operating Income returned to growth in FY2022 after 3 years of decline, reaching -$88M.
Based on SEC 10-K filings.
-$88M in FY2022.
Declined from -$76M to -$88M over the past 2 years.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2022, operating income increased 25.9% year-over-year.
- Peak operating income was recorded in FY2018.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Altman Z-Score 1.22 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | -$88.4M | +25.9% |
| FY2021 | -$119.3M | -57.6% |
| FY2020 | -$75.7M | -38.0% |
| FY2019 | -$54.9M | -114.5% |
| FY2018 | -$25.6M | - |
As of FY2022 · SEC 10-K · Updated Jun 28, 2026